Characteristics | ERAS Group (n = 155) | Control Group (n = 158) | P |
---|---|---|---|
Primary outcome LOS (days) | 5.92 ± 1.16 | 8.17 ± 1.76 | 0.000c |
Secondary outcomes | |||
 Postoperative LOS (days)a | 4.06 ± 1.09 | 6.06 ± 1.87 | 0.000c |
 Time to independent ambulation (hours)a | 5.02 ± 1.76 | 6.30 ± 1.80 | 0.000c |
 Day 1 resting pain NRS score [None/Mild/Moderate (%)]b | 115/37/3 (74.2%/23.9%/1.9%) | 71/72/15 (44.9%/45.6%/9.5%) | 0.000c |
 Day 1 movement pain NRS score [None/Mild/Moderate/Severe (%)]b | 44/64/47/0 (28.4%/41.2%/30.4%/0%) | 17/38/97/6 (10.8%/24.1%/61.4%/3.8%) | 0.000c |
 Postoperative analgesia [Yes/No (%)]b | 40/115 (25.8%) | 76/82 (48.1%) | 0.000c |
 Thirst [Yes/No (%)]b | 26/129 (16.8%) | 140/158 (88.6%) | 0.000c |
 Postoperative nausea and vomiting [Yes/No (%)]b | 4/151 (2.6%) | 39/119 (24.7%) | 0.000c |
 Postoperative complications [Yes/No (%)]b | 6/149 (3.9%) | 11/146 (7.0%) | 0.290 |